| Literature DB >> 23589030 |
Kunie Ando1, Jean-Pierre Brion, Virginie Stygelbout, Valérie Suain, Michèle Authelet, Robert Dedecker, Anaïs Chanut, Pascale Lacor, Jérémie Lavaur, Véronique Sazdovitch, Ekaterina Rogaeva, Marie-Claude Potier, Charles Duyckaerts.
Abstract
PICALM, a clathrin adaptor protein, plays important roles in clathrin-mediated endocytosis in all cell types. Recently, genome-wide association studies identified single nucleotide polymorphisms in PICALM gene as genetic risk factors for late-onset Alzheimer disease (LOAD). We analysed by western blotting with several anti-PICALM antibodies the pattern of expression of PICALM in human brain extracts. We found that PICALM was abnormally cleaved in AD samples and that the level of the uncleaved 65-75 kDa full-length PICALM species was significantly decreased in AD brains. Cleavage of human PICALM after activation of endogenous calpain or caspase was demonstrated in vitro. Immunohistochemistry revealed that PICALM was associated in situ with neurofibrillary tangles, co-localising with conformationally abnormal and hyperphosphorylated tau in LOAD, familial AD and Down syndrome cases. PHF-tau proteins co-immunoprecipitated with PICALM. PICALM was highly expressed in microglia in LOAD. These observations suggest that PICALM is associated with the development of AD tau pathology. PICALM cleavage could contribute to endocytic dysfunction in AD.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23589030 DOI: 10.1007/s00401-013-1111-z
Source DB: PubMed Journal: Acta Neuropathol ISSN: 0001-6322 Impact factor: 17.088